Mohamed Adam, MD
Assistant Professor
Surgery
School of Medicine

Publications (5)

Top publication keywords:
AdenocarcinomaPeritoneal NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsSurvival RateHyperthermia, InducedChemotherapy, AdjuvantJudgmentCytoreduction Surgical ProceduresNeoadjuvant TherapyAdultHumansCombined Modality TherapyRetrospective StudiesPancreatic Neoplasms

• ASO Visual Abstract: Predicting Severe Complications from Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy-A Data-Driven, Machine Learning Approach to Augment Clinical Judgement.
  Annals of surgical oncology 2023 Adam MA, Zhou H, Byrd J, Greenberg AL, Kelly YM, Hall L, Jones HL, Pingpank JF, Lipton ZC, Bartlett DL, Choudry HM
• Predicting Severe Complications from Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: A Data-Driven, Machine Learning Approach to Augment Clinical Judgment.
  Annals of surgical oncology 2023 Adam MA, Zhou H, Byrd J, Greenberg AL, Kelly YM, Hall L, Jones HL, Pingpank JF, Lipton ZC, Bartlett DL, Choudry HM
• Neoadjuvant Therapy Versus Upfront Resection for Nonpancreatic Periampullary Adenocarcinoma.
  Annals of surgical oncology 2022 Adam MA, Glencer A, AlMasri S, Winters S, Bahary N, Singhi A, Lee KK, Paniccia A, Zureikat AH
• ASO Author Reflections: Neoadjuvant Therapy for Nonpancreatic Periampullary Adenocarcinoma.
  Annals of surgical oncology 2022 Adam MA, Glencer AC, Zureikat AH
• ASO Author Reflections: Neoadjuvant Chemotherapy for Pancreatic Adenocarcinoma Lessens the Deleterious Effect of Omission of Adjuvant Chemotherapy.
  Annals of surgical oncology 2021 Adam MA, Paniccia A